Skip to main content
Clinical Trials/NL-OMON51942
NL-OMON51942
Recruiting
Not Applicable

Follow-up after treatment for testicular cancer: the prospective, single centre FUTURE-testis implementation study - FUTURE-testis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Testicular cancer
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
145
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age \>\= 18 years.
  • Histologically confirmed testicular cancer without distant metastasis and
  • treated with curative intent less than 6 months ago:
  • o Non\-seminomatous germ cell tumours, stage I low risk:
  • \* No lymphadenopathy or metastases on the postoperative scan.
  • \* Three consecutive blood drawings with normal tumour markers.
  • \* Patients undergoing lymph node dissection as a second curative operation
  • after an orchiectomy, can
  • also be included in case that the postoperative scan shows no
  • residual disease or metastases.

Exclusion Criteria

  • Patients with aberrant levels of LDH preoperatively (LDH \>248 U/L). •
  • Patients with a severely complicated postoperative course, needing in hospital
  • follow\-up longer than 6 months postoperatively • Patients enrolled in other
  • studies that require strict adherence to any specific follow\-up practice with
  • regular imaging \- yearly or more frequent \- of the abdomen and/or thorax •
  • Patients with comorbidity or other malignancy that requires imaging of the
  • abdomen and/or thorax every year or more frequent • Inability to complete the
  • questionnaires due to illiteracy and/or insufficient proficiency of the Dutch

Outcomes

Primary Outcomes

Not specified

Similar Trials